Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 4;16(6):e0251314.
doi: 10.1371/journal.pone.0251314. eCollection 2021.

Detection of genotype-1 of dengue virus serotype 3 for the first time and complete genome analysis of dengue viruses during the 2018 epidemic in Mandalay, Upper Myanmar

Mya Myat Ngwe Tun  1 , Aung Kyaw Kyaw  2 , Takeshi Nabeshima  1 , Aung Min Soe  1   2 , Khine Mya Nwe  1 , Kyaw Ko Ko Htet  2 , Thet Htoo Aung  2 , Thein Thein Htwe  2 , Thidar Aung  2 , Su Su Myaing  2 , Tu Tu Mar  2 , Ei Phyu Lwin  3 , Hlaing Myat Thu  2 , Kyaw Zin Thant  4 , Kouichi Morita  1
Affiliations

Detection of genotype-1 of dengue virus serotype 3 for the first time and complete genome analysis of dengue viruses during the 2018 epidemic in Mandalay, Upper Myanmar

Mya Myat Ngwe Tun et al. PLoS One. .

Abstract

Background: Dengue (DEN) is a neglected tropical disease, and surveillance of dengue virus (DENV) serotypes and genotypes is critical for the early detection of outbreaks. Risk factors for outbreaks include the emergence of new genotypes and serotype shifting.

Methodology and principal findings: To understand the genomic and viral characteristics of DENV-infected patients, we conducted a cross-sectional descriptive study among pediatric patients admitted at the 550-bedded Mandalay Children Hospital during the 2018 DEN endemic season. We conducted virus isolation, serological tests, viremia level measurement, and whole-genome sequencing. Among the 202 serum samples, we detected 85 samples with DENV (46 DENV-1, 10 DENV-3, 26 DENV-4 and three multiple serotype co-infections) via reverse transcription quantitative/real-time PCR (RT-qPCR), and we obtained 49 DENV isolates (31 DENV-1, 10 DENV-3 and 8 DEN-4). We did not detect DENV-2 in this study. The viral genome levels in serum did not differ significantly among virus serotypes, infection status (primary versus secondary) and disease severity. Based on the phylogenetic analysis, we identified DENV-1 genotype-1, DENV-4 genotype-1 and DENV-3 genotype-3 and genotype-1 which was detected for the first time. Next-generation sequencing analysis revealed greater frequencies of nonsynonymous and synonymous mutations per gene in the nonstructural genes. Moreover, mutation rates were also higher among DENV-1.

Conclusion/significance: In conclusion, there was an increasing trend of DENV-3 cases during DENV endemic season in 2018 with the first detection of the genotype 1. However, DENV-1 has remained the predominant serotype in this study area since 2013, and we identified stop codon mutations in the DENV-1 genome. This report is the first to feature a complete genome analysis of the strains of DENV-3 and DENV-4 circulating among pediatric patients in Myanmar. This study highlighted the importance of annual surveillance for a better understanding of the molecular epidemiology of DENVs.

PubMed Disclaimer

Conflict of interest statement

No authors have competing interests.

Figures

Fig 1
Fig 1. Phylogenetic trees based on the full coding region of the envelope protein gene of (A) DENV-1 (B) DENV-3 and (C) DENV-4.
The representative strains of each genotype obtained from Genbank were named by country origin, strain name, year of isolation and GenBank accession number.
Fig 2
Fig 2. Number of positions with variant incidence > 1% per gene among the DENV-isolates.
(A) DENV-1, (B) DENV-3 and (C) DENV-4.
See this image and copyright information in PMC

References

    1. Leta S, Beyene TJ, De Clercq EM, Amenu K, Kraemer MUG, Revie CW. Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus. Int J Infect Dis. 2018;67:25–35. Epub 2017/12/03. doi: 10.1016/j.ijid.2017.11.026 ; PubMed Central PMCID: PMC5976855. - DOI - PMC - PubMed
    1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al.. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7. doi: 10.1038/nature12060 . - DOI - PMC - PubMed
    1. WHO. World Health Organization. Dengue Guidelines for Diagnosis, Treatment, Prevention, and Control. Geneva. 2009. - PubMed
    1. Kyaw AK, Ngwe Tun MM, Moi ML, Nabeshima T, Soe KT, Thwe SM, et al.. Clinical, virological and epidemiological characterization of dengue outbreak in Myanmar, 2015. Epidemiol Infect. 145. England2017. p. 1886–97. doi: 10.1017/S0950268817000735 - DOI - PMC - PubMed
    1. Ngwe Tun MM, Kyaw AK, Makki N, Muthugala R, Nabeshima T, Inoue S, et al.. Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype. Infect Genet Evol. 43: 2016. Elsevier B.V; 2016. p. 31–7. doi: 10.1016/j.meegid.2016.04.025 - DOI - PubMed

Publication types